covid 19 News and Research

RSS

As more red states legalize marijuana, some officials try to nip it in the bud

With his state reeling amid one of the worst COVID-19 outbreaks in the nation, the last thing South Dakota Speaker of the House Steven Haugaard wants to be dealing with during the upcoming legislative session is marijuana. But the state's voters haven't left the Republican much choice.

9 Dec 2020

It’s time to scare people about COVID

I still remember exactly where I was sitting decades ago, during the short film shown in class: For a few painful minutes, we watched a woman talking mechanically, raspily through a hole in her throat, pausing occasionally to gasp for air.

9 Dec 2020

Predicting SARS-CoV-2 protein sequences

SARS-CoV-2, the causative agent of COVID-19, consists of an assembly of proteins that determine its infectious and immunological behavior.

9 Dec 2020

Developing antimicrobial products with resistance to coronavirus

In this interview, News-Medical spoke to Charles Churchman, Co-founder of Veraco, about their antimicrobial products that have been designed to have resistance to coronavirus.

9 Dec 2020

HIV/AIDS testing and treatment can be adapted to achieve similar interventions to mitigate COVID-19

A research project is exploring whether interventions that have been effective at engaging high-risk populations in HIV/AIDS testing and treatment can be adapted to achieve similar effects in mitigating COVID-19.

9 Dec 2020

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease, with no hospitalizations or severe disease reported in the COVID-19 vaccine group so far.

9 Dec 2020

Researchers compare data from blood donors to infer the attack rate of SARS-CoV-2 virus

Researchers studying data from blood donors in Manaus, Brazil, who experienced high mortality from SARS-CoV-2, estimate that more than 70% of the population was infected approximately seven months after the virus first arrived in the city.

9 Dec 2020

COVID-19 lockdown measures negatively impact children's mental health

The first lockdown led to a significant increase in symptoms of depression among children, highlighting the unintended consequences of school closures, according to a new study from the University of Cambridge.

9 Dec 2020

Scientists determine key molecular processes used by coronavirus to infect human cells

When a coronavirus--including SARS-CoV-2, which causes COVID-19--infects someone, it hijacks the person's cells, co-opting their molecular machinery for its own survival and spread.

9 Dec 2020

Researchers share key solutions related to challenges faced by businesses during COVID-19

Researchers share important information and solutions related to the challenges facing human resources and system managers in a special issue of Human Systems Management

8 Dec 2020

New report underscores the need to implement home care in all pandemic planning

Tens of thousands of Massachusetts residents depend on home care to support their health as they age or cope with physical challenges. That care often requires close personal contact, increasing the risk of contracting COVID-19 among both home-care clients and the aides who provide their care.

8 Dec 2020

Researchers explore the effect of COVID-19 pandemic on the environment

COVID-19 has changed the way we live and work, as various health and safety restrictions keep more of us at home more often.

8 Dec 2020

Researchers assess the binding behavior of SARS-CoV-2 virus

The binding of a SARS-CoV-2 virus surface protein spike -- a projection from the spherical virus particle -- to the human cell surface protein ACE2 is the first step to infection that may lead to COVID-19 disease.

8 Dec 2020

Amilorides reduce SARS-CoV-2 viral replication in vitro

A new U.S. study published on the bioRxiv preprint server reports the use of an amiloride-based scaffold that targets a viral RNA structure known to be essential in viral replication in the 5’-untranslated region (UTR) of the virus. The researchers say this heralds the application of these molecules as chemical probes to explore viral biology and produce specific antivirals targeting RNA regions of the coronavirus genome.

8 Dec 2020

$Using fractional exponents in epidemic models could improve predictions of disease spread$

Using fractional exponents in epidemic models could improve predictions of disease spread

A new class of epidemiological models based on alternative thinking about how contagions propagate, particularly in the early phases of a pandemic, provide a blueprint for more accurate epidemic modeling and improved disease spread predictions and responses, according to a study published recently in Scientific Reports by researchers at the University of California, Irvine and other institutions.

8 Dec 2020

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

Despite the encouraging news of potentially successful COVID-19 vaccine trials, there is not yet an FDA-approved vaccine available. Research into other effective coronavirus vaccines continues, including at UC Davis Health.

8 Dec 2020

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

A new study published on the preprint server bioRxiv in December 2020 reveals the role played by certain genetic factors in this group, in particular the FASLG gene belonging to the tumor necrosis factor (TNF) family.

8 Dec 2020

Troublesome COVID-19 symptoms could last more than 6 weeks

Physicians in Geneva have shown that some of the troublesome symptoms of COVID-19 could last more than 6 weeks, even in patients without underlying risk factors.

8 Dec 2020

New 'nanoPCR' technology can accurately diagnose COVID-19 in less than 20 minutes

A "nanoPCR" technology was developed for the point-of-care (POC) diagnosis of coronavirus disease-19 (COVID-19).

8 Dec 2020

High-performing multi-immunoassay for early diagnosis and prognosis of COVID-19

A new study published on the preprint server bioRxiv in December 2020 indicates the ability of anti-SARS-CoV-2 antibody titers and time of induction to differentiate between severe and mild COVID-19 and could lead to the development of a prognostic biomarker for use early in the course of the illness.

8 Dec 2020

covid 19 News and Research

As more red states legalize marijuana, some officials try to nip it in the bud

It’s time to scare people about COVID

Predicting SARS-CoV-2 protein sequences

Developing antimicrobial products with resistance to coronavirus

HIV/AIDS testing and treatment can be adapted to achieve similar interventions to mitigate COVID-19

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

Researchers compare data from blood donors to infer the attack rate of SARS-CoV-2 virus

COVID-19 lockdown measures negatively impact children's mental health

Scientists determine key molecular processes used by coronavirus to infect human cells

Researchers share key solutions related to challenges faced by businesses during COVID-19

New report underscores the need to implement home care in all pandemic planning

Researchers explore the effect of COVID-19 pandemic on the environment

Researchers assess the binding behavior of SARS-CoV-2 virus

Amilorides reduce SARS-CoV-2 viral replication in vitro

Using fractional exponents in epidemic models could improve predictions of disease spread

UC Davis Health joins with Novavax to test a new experimental coronavirus vaccine

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

Troublesome COVID-19 symptoms could last more than 6 weeks

New 'nanoPCR' technology can accurately diagnose COVID-19 in less than 20 minutes

High-performing multi-immunoassay for early diagnosis and prognosis of COVID-19

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News